FreeOx Biotech: Advancing Stroke Care through Innovation and Precision Medicine
FreeOx Biotech is a pioneering late-stage clinical biotechnology company dedicated to transforming acute ischemic stroke (AIS) management. Our mission is to improve outcomes for stroke patients through the discovery and development of Cerebrovascular Protective Therapeutics.
Our lead asset, Ox-01, is a Phase 3-ready investigational drug with breakthrough potential as an emergency adjunct therapy to Mechanical Thrombectomy. Selected by the prestigious StrokeNet Thrombectomy Endovascular Platform (STEP) program, funded by the National Institute of Neurological Disorders and Stroke (NINDS), Ox-01 represents a paradigm shift in AIS treatment.
Backed by strong scientific evidence and a commitment to innovation, FreeOx Biotech is at the forefront of addressing one of the most critical unmet needs in cerebrovascular care.
Company Details
- Employees
- 7
- Founded
- -
- Address
- C/ Consell De Cent 373, 2-1, Barcelona,barcelona 08009,spain
- in****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- freeoxbiotech.com
- Keywords
- Stroke, Oxidative stress, Neuroprotective therapies, Health research, Biotechnology, Clinical research.
- HQ
- Barcelona, Barcelona
Freeox Biotech Questions
Freeox Biotech's website is freeoxbiotech.com
Freeox Biotech's LinkedIn profile is https://es.linkedin.com/company/freeox-biotech
Freeox Biotech has
7 employees.
View email and phone details for 7
employees at Freeox Biotech.
Freeox Biotech's industry is
Biotechnology Research
Freeox Biotech's top competitors are
Aelix Therapeutics,
Oniria Therapeutics,
Ona Therapeutics,
Leukos Biotech,
Biotech Tricopharming Research,
Elem Biotech,
Pulmobiotics Sl,
Onechain Immunotherapeutics,
Ipsen,
Monzon Biotech S.l..
Freeox Biotech's support email address is info@freeoxbiotech.com
Freeox Biotech's categories are Biotechnology Research
Freeox Biotech's founding year is 2017
